Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 7
2004 1
2005 2
2006 1
2007 5
2008 2
2009 6
2010 6
2011 7
2012 13
2013 12
2014 11
2015 9
2016 5
2017 4
2018 5
2019 8
2020 12
2021 8
2022 2
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

117 results

Results by year

Filters applied: . Clear all
Page 1
Lung Cancer in Austria.
Pirker R, Prosch H, Popper H, Klepetko W, Dieckmann K, Burghuber OC, Klikovits T, Hoda MA, Zöchbauer-Müller S, Filipits M. Pirker R, et al. Among authors: filipits m. J Thorac Oncol. 2021 May;16(5):725-733. doi: 10.1016/j.jtho.2020.10.158. J Thorac Oncol. 2021. PMID: 33896572 Free article. No abstract available.
Cetuximab in non-small-cell lung cancer.
Pirker R, Filipits M. Pirker R, et al. Among authors: filipits m. Transl Lung Cancer Res. 2012 Mar;1(1):54-60. doi: 10.3978/j.issn.2218-6751.11.01. Transl Lung Cancer Res. 2012. PMID: 25806155 Free PMC article. Review.
The potential of liquid biopsies.
Buder A, Tomuta C, Filipits M. Buder A, et al. Among authors: filipits m. Curr Opin Oncol. 2016 Mar;28(2):130-4. doi: 10.1097/CCO.0000000000000267. Curr Opin Oncol. 2016. PMID: 26730486 Review.
Differential immunomodulatory effects of epirubicin/cyclophosphamide and docetaxel in breast cancer patients.
Wimmer K, Sachet M, Ramos C, Frantal S, Birnleitner H, Brostjan C, Exner R, Filipits M, Bago-Horvath Z, Rudas M, Bartsch R, Gnant M, Singer CF, Balic M, Egle D, Oehler R, Fitzal F. Wimmer K, et al. Among authors: filipits m. J Exp Clin Cancer Res. 2023 Nov 14;42(1):300. doi: 10.1186/s13046-023-02876-x. J Exp Clin Cancer Res. 2023. PMID: 37957750 Free PMC article. Clinical Trial.
Pertuzumab in breast cancer: a systematic review.
Zagouri F, Sergentanis TN, Chrysikos D, Zografos CG, Filipits M, Bartsch R, Dimopoulos MA, Psaltopoulou T. Zagouri F, et al. Among authors: filipits m. Clin Breast Cancer. 2013 Oct;13(5):315-24. doi: 10.1016/j.clbc.2013.05.002. Epub 2013 Jun 27. Clin Breast Cancer. 2013. PMID: 23810292 Review.
mTOR inhibitors in breast cancer: a systematic review.
Zagouri F, Sergentanis TN, Chrysikos D, Filipits M, Bartsch R. Zagouri F, et al. Among authors: filipits m. Gynecol Oncol. 2012 Dec;127(3):662-72. doi: 10.1016/j.ygyno.2012.08.040. Epub 2012 Sep 9. Gynecol Oncol. 2012. PMID: 22967800 Review.
117 results